Trial Profile
A 2-part, open-label, multiple-dose, pharmacokinetic interactions and tolerability study of MK-5172 and Tenofovir or Raltegravir in healthy adult
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Dec 2015
Price :
$35
*
At a glance
- Drugs Grazoprevir (Primary) ; Raltegravir; Tenofovir
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- 17 Dec 2015 New trial record